XSWX
BARN
Market cap8.43bUSD
Dec 04, Last price
1,236.00CHF
1D
1.31%
1Q
9.57%
Jan 2017
-0.80%
Name
Barry Callebaut AG
Chart & Performance
P/E
35.71
P/S
0.65
EPS
34.62
Div Yield, %
2.35%
Shrs. gr., 5y
-60.22%
Rev. gr., 5y
7.28%
Revenues
10.39b
+22.62%
Net income
190m
-57.29%
CFO
-2.06b
L
Dividend
Jan 08, 202429 CHF/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Barry Callebaut AG, together with its subsidiaries, engages in the manufacture and sale of chocolate and cocoa products. The company provides chocolates, compounds, chips and chunks, cocoa, cacao fruit, fillings, coatings, nuts, decorations and inclusions, and food colorants, as well as personalization sheets. It also offers cocoa powder, chocolate drinks, cappuccinos, dessert drinks, dairy and non-dairy products, tea, and coffee. The company provides products under the ASM, Barry Callebaut, Cacao Barry, Callebaut, Carma, Chocovic, Mona Lisa, Gertrude Hawk Ingredients, Van Houten Professional, Bensdorp, Cabosse Naturals, Caprimo, D'Orsogna Dolciaria, IBC, and La Morella Nuts names. In addition, it offers centralized treasury and management services; research and development; insurance; and conference and training services offered through CHOCOLATE ACADEMY centers. The company serves food manufacturers and artisans; and professional users of chocolate, including chocolatiers, pastry chefs, bakers, hotels, restaurants, or caterers. It also offers products for vending machines. The company operates primarily in the United States, Germany, the United Kingdom, Belgium, France, Mexico, Brazil, Poland, Switzerland, rest of Europe, rest of Americas, and the Asia Pacific. Barry Callebaut AG was incorporated in 1996 and is headquartered in Zürich, Switzerland.
IPO date
Jun 15, 1998
Employees
13,672
Domiciled in
CH
Incorporated in
CH
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | 2016‑08 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||